KM Research Hub

P1 · PANEL / ROI / AXIS GROUND TRUTH

原 EXE 对齐基准真值复核

所有保存均写入追加式审计事件;旧标注、旧比较和旧提取结果不会被删除或覆盖。

返回质量诊断
冻结记录120
真值完整117
待复核0
无效/退役3
← 上一例 Case 74 / 120 · DB #74 下一例 →
multi_panel pending PMID 41490515

A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

fig2 · Panel B · Overall survival (OS)

Figure 2. Primary and secondary end points. (A) EFS in the ITT population. In this EFS analysis, molecular persistence or molecular relapse are considered as treatment failure. There was no statistically significant difference in EFS between treatment arms (HR, 0.92; 95% CI, 0.63-1.33; stratified log-rank test, P = .66). (B) OS. There was no statistically significant difference in OS between treatment arms (HR, 0.93; 95% CI, 0.53-1.63; stratified log-rank test, P = .79). (C) RFS. There was no statistically significant difference in RFS between treatment arms (HR, 0.82; 95% CI, 0.55-1.21; stratified log-rank test, P = .31).
打开论文记录

坐标框复核

洋红 = 当前 Linux 候选;绿色 = 已保存人工真值。没有绿色框表示仍未形成真值。

Case 74 ROI review overlay
当前候选 {'x0': 124, 'y0': 90, 'x1': 728, 'y1': 398} 人工真值 {'x0': 124, 'x1': 728, 'y0': 90, 'y1': 398}
生产预期曲线2
当前恢复曲线2
算法版本legacy-0.5.0
坐标 OCR不完整/待核
查看候选 OCR 与警告(只能作种子,不能自证真值)
{
  "complete": false,
  "engine": "RapidOCR",
  "plot_bottom": 383,
  "plot_left": 152,
  "plot_right": 727,
  "plot_top": 105,
  "warnings": [
    "insufficient_x_ticks"
  ],
  "x_axis_y": 383,
  "x_confidence": 0.0,
  "x_detected": false,
  "x_max": null,
  "x_min": null,
  "x_ticks": [],
  "y_axis_x": 152,
  "y_confidence": 1.0,
  "y_detected": true,
  "y_max": 1,
  "y_min": 0,
  "y_ticks": [
    {
      "box": [
        [
          61.0,
          92.0
        ],
        [
          108.0,
          92.0
        ],
        [
          108.0,
          117.0
        ],
        [
          61.0,
          117.0
        ]
      ],
      "confidence": 0.9998434782028198,
      "pixel": 104.5,
      "text": "1.00",
      "value": 1.0
    },
    {
      "box": [
        [
          58.0,
          163.0
        ],
        [
          106.0,
          163.0
        ],
        [
          106.0,
          186.0
        ],
        [
          58.0,
          186.0
        ]
      ],
      "confidence": 0.9998697340488434,
      "pixel": 174.5,
      "text": "0.75",
      "value": 0.75
    },
    {
      "box": [
        [
          59.0,
          232.0
        ],
        [
          108.0,
          232.0
        ],
        [
          108.0,
          256.0
        ],
        [
          59.0,
          256.0
        ]
      ],
      "confidence": 0.9999150335788727,
      "pixel": 244.0,
      "text": "0.50",
      "value": 0.5
    },
    {
      "box": [
        [
          61.0,
          303.0
        ],
        [
          108.0,
          303.0
        ],
        [
          108.0,
          324.0
        ],
        [
          61.0,
          324.0
        ]
      ],
      "confidence": 0.999866396188736,
      "pixel": 313.5,
      "text": "0.25",
      "value": 0.25
    },
    {
      "box": [
        [
          60.0,
          371.0
        ],
        [
          108.0,
          371.0
        ],
        [
          108.0,
          395.0
        ],
        [
          60.0,
          395.0
        ]
      ],
      "confidence": 0.9997357875108719,
      "pixel": 383.0,
      "text": "0.00",
      "value": 0.0
    }
  ]
}
查看当前 Linux 输出

追加一条审查结论

选择“有效 KM”时,四边 ROI、四个坐标范围、Panel、终点和曲线数均为必填。

像素 ROI(x1/y1 为排他边界)
真实坐标范围

追加式审计历史

最新事件仅作为当前缓存;以下每一条既往结论都永久保留。

事件时间 / 审查人状态ROI坐标说明
#77p1-visual-axis-audit-v2 · frozen benchmark contact sheets + original images + RapidOCR re-audit 2026-07-28T15:12:18+00:00Codex-assisted visual audit valid_km {'x0': 124, 'x1': 728, 'y0': 90, 'y1': 398} X 0.0–10.0 / Y 0.0–1.0 P1 冻结原图审查;人工检查冻结原图刻度;ROI 四边按可见坐标轴框记录。

最近一次正式比较

Suite #3 · 2026-07-28T15:15:12+00:00

未通过

真值完整 117 / 120;通过 0;缺真值 0;无效案例 3。